Positron emission tomography imaging as a cancer biomarker

Evan Y Yu1, David A Mankoff

  • 1Seattle Cancer Care Alliance, Division of Medical Oncology, 825 Eastlake Avenue East, G4-836, Seattle, WA 98109, USA. evanyu@u.washington.edu

Insights

Novel biologic agents are transforming oncology, necessitating new biomarkers for individualized cancer care. Positron Emission Tomography (PET) imaging shows promise in discovering these biomarkers to guide targeted therapies and improve patient outcomes.

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Molecular Imaging

Background:

  • The practice of oncology is evolving with the introduction of novel biologic agents.
  • Cancer treatment is shifting towards individualized care, driven by tumor heterogeneity.
  • There is a critical need for biomarkers to guide personalized therapeutic strategies.

Purpose of the Study:

  • To review the development of cancer biomarkers.
  • To explore the role of Positron Emission Tomography (PET) in elucidating tumor biology.
  • To discuss the potential clinical applications of PET in cancer research and practice.

Main Methods:

  • Review of current literature on cancer biomarker development.
  • Discussion of metabolic and molecular imaging techniques, particularly PET.
  • Analysis of the utility of PET in understanding tumor characteristics.

Main Results:

  • Biomarker discovery is essential for advancing individualized cancer therapy.
  • PET imaging offers significant opportunities to reveal critical aspects of tumor biology.
  • PET has the potential to enhance drug development and clinical decision-making.

Conclusions:

  • Individualized cancer care requires robust biomarker identification.
  • PET imaging is a powerful tool for biomarker discovery and tumor characterization.
  • Integrating PET into clinical research and practice can optimize cancer treatment strategies.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...